Replacement of an implantable cardioverter-defibrillator (ICD) with a new standard subcutaneous ICD system in a patient with jervell and lange-nielsen syndrome

Abstract

A 7-year-old female suffering from syncope attacks and deafness was genetically diagnosed with Jervell and Lange-Nielsen syndrome (JLNS). A transvenous-designed shock lead and implantable cardioverterdefibrillator (ICD) were atypically implanted subcutaneously, because the patient’s body was small. Six years after implantation, we confirmed the patient’s eligibility for a subcutaneous ICD (S-ICD) based on electrocardiogram screening. The implanted ICD system was replaced with a new standard S-ICD system. Implantation of the S-ICD may be considered a reliable and safe option in young patients with JLNS, even if their electrocardiograms show remarkable prolongation of the QT interval and T-wave alternans.